Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Theravance: A $1.5 Billion Company With An $8 Billion Product
Seeking Alpha
Wed, 02/22/12 - 05:47 pm
Tags:
Theravance, GSK, Pfizer, Relovair, Advair, AstraZeneca, asthma, COPD
AstraZeneca announces first direct-to-patient program offering ARIMIDEX
The Fly on the Wall
Thu, 02/16/12 - 09:29 am
Tags:
Arimidex, AstraZeneca, Express Scripts
Selling Drugs: Small Biotech Stocks With Strong Sales Growth
Seeking Alpha
Tue, 02/14/12 - 11:21 am
Tags:
AstraZeneca, Cephalon, Dendreon, Forest Labs, Human Genome Sciences, Jazz Pharmaceuticals, Pfizer, Teva Pharmaceuticals, Spectrum Pharmaceuticals
Which Pharma Spent The Most R&D On Each Drug?
Pharmalot
Fri, 02/10/12 - 10:54 am
Tags:
R&D, Amgen, AstraZeneca, Abbott Laboratories, Eli Lilly
Biotech Stocks To Watch In 2012
Seeking Alpha
Mon, 02/6/12 - 11:20 am
Tags:
Astellas, Array Biopharma, AstraZeneca, Celldex, Exelixis, Pfizer, Progenics Pharmaceuticals, Seattle Genetics, Synta
Small Pharma With Big Compounds: Final Dance With The FDA
Seeking Alpha
Mon, 02/6/12 - 09:42 am
Tags:
GSK, AstraZeneca, FDA, Eli Lilly, Pfizer, Vivus, Merck, MAP Pharmaceuticals
AstraZeneca's Shrinking Act Could Increase Its Appeal
Seeking Alpha
Sun, 02/5/12 - 12:18 pm
Tags:
AstraZeneca
AstraZeneca - Solid Earnings Overwhelmed By An Uncertain Future
Seeking Alpha
Sat, 02/4/12 - 04:34 pm
Tags:
AstraZeneca
FDA talks, but doctors don't necessarily listen
Fierce Pharma
Fri, 02/3/12 - 11:57 am
Tags:
FDA, physicians, warnings, Eli Lilly, Zyprexa, AstraZeneca, Seroquel
AstraZeneca Declines Most in 5 Months on Forecast: London Mover
Bloomberg
Fri, 02/3/12 - 09:58 am
Tags:
guidance, AstraZeneca
AstraZeneca to cut 7,300 jobs, post lower profit
Marketwatch
Thu, 02/2/12 - 09:13 am
Tags:
layoffs, AstraZeneca, guidance
Impax Labs licenses Astrazeneca's migraine drug in US
Reuters
Wed, 02/1/12 - 11:31 am
Tags:
AstraZeneca, Impax Labs, migraines, Zomig
AstraZeneca May Shed Thousands More Jobs
Pharmalot
Mon, 01/30/12 - 12:08 pm
Tags:
layoffs, AstraZeneca
19 Clinical Trials Aren't Enough
Motley Fool
Sat, 01/21/12 - 04:44 pm
Tags:
Dapagliflozin, AstraZeneca, Bristol-Myers Squibb, diabetes
AZ chief: Emerging markets are tougher than you think
Fierce Pharma
Thu, 01/19/12 - 12:05 pm
Tags:
AstraZeneca, emerging markets, David Brennan, Pharma CEOs
Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Bloomberg
Thu, 01/19/12 - 10:38 am
Tags:
AstraZeneca, FDA, Bristol-Myers Squibb, diabetes, Dapagliflozin
Why Big Pharma Doesn't Really Need (Or Even Want) A Pipeline
Seeking Alpha
Tue, 01/17/12 - 06:48 pm
Tags:
Adolor, Alexion, Amgen, Cubist Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Inhibitex, Merck, Pfizer, Stryker
Europe’s Drugmakers May Boost Acquisitions After Buyback Focus
Bloomberg Businessweek
Thu, 01/12/12 - 02:11 pm
Tags:
Europe, M&A, patents, GSK, Roche, AstraZeneca, Novartis
Is 'Worthless' Really A Fair Assessment Of Targacept?
Seeking Alpha
Thu, 01/12/12 - 02:02 pm
Tags:
Targacept, Forest Labs, AstraZeneca, Pfizer, JNJ
There have been red faces at AstraZeneca after the company sent confidential information to analysts by mistake
InPharm
Mon, 01/9/12 - 10:14 am
Tags:
guidance, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.